Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-03-14 Sale | 2024-03-15 4:01 pm | REGENERON PHARMACEUTICALS INC. | REGN | MURPHY ANDREW J EVP Research | 5,783 | $956.47 | $5,531,290 | 72,616 (Indirect Direct) | View |
2024-03-01 Sale | 2024-03-05 4:01 pm | REGENERON PHARMACEUTICALS INC. | REGN | RYAN ARTHUR F Director | 100 | $982.05 | $98,205 | 18,282 (Direct) | View |
2024-03-01 Sale | 2024-03-05 4:01 pm | REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial | 358 | $967.5 | $346,365 | 13,589 (Indirect Direct) | View |
2024-02-26 Sale | 2024-02-28 4:04 pm | REGENERON PHARMACEUTICALS INC. | REGN | LAROSA JOSEPH J EVP General Counsel and Secret | 1,000 | $990 | $990,000 | 40,265 (Indirect Direct) | View |
2024-02-26 Sale | 2024-02-28 4:04 pm | REGENERON PHARMACEUTICALS INC. | REGN | SING GEORGE L Director | 1,000 | $992.5 | $992,500 | 33,837 (Indirect Direct) | View |
2024-02-26 Sale | 2024-02-26 4:07 pm | REGENERON PHARMACEUTICALS INC. | REGN | Bassler Bonnie L Director | 854 | $979.25 | $836,280 | 1,382 (Direct) | View |
2024-02-22 Sale | 2024-02-26 4:07 pm | REGENERON PHARMACEUTICALS INC. | REGN | LAROSA JOSEPH J EVP General Counsel and Secret | 1,000 | $967.65 | $967,650 | 41,265 (Indirect Direct) | View |
2024-02-22 Sale | 2024-02-26 4:07 pm | REGENERON PHARMACEUTICALS INC. | REGN | SING GEORGE L Director | 3,500 | $967.86 | $3,387,500 | 41,675 (Indirect Direct) | View |
2024-02-14 Sale | 2024-02-16 4:15 pm | REGENERON PHARMACEUTICALS INC. | REGN | Van Plew Daniel P EVP & General Mgr, Industrial | 10,434 | $942.28 | $9,831,727 | 33,838 (Indirect Direct) | View |
2024-02-08 Sale | 2024-02-12 4:02 pm | REGENERON PHARMACEUTICALS INC. | REGN | SING GEORGE L Director | 1,000 | $950 | $950,000 | 48,675 (Indirect Direct) | View |
2024-02-09 Sale | 2024-02-12 4:02 pm | REGENERON PHARMACEUTICALS INC. | REGN | Fenimore Christopher R. SVP Finance & CFO | 4,919 | $953.31 | $4,689,320 | 24,431 (Indirect Direct) | View |
2024-02-07 Sale | 2024-02-09 4:12 pm | REGENERON PHARMACEUTICALS INC. | REGN | LAROSA JOSEPH J EVP General Counsel and Secret | 1,000 | $950 | $950,000 | 42,265 (Indirect Direct) | View |
2024-02-07 Sale | 2024-02-08 4:02 pm | REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development | 8,037 | $950.35 | $7,637,954 | 62,458 (Indirect Direct) | View |
2024-02-05 Sale | 2024-02-06 4:08 pm | REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial | 1,000 | $934.71 | $934,710 | 13,947 (Indirect Direct) | View |
2024-02-01 Sale | 2024-02-05 4:05 pm | REGENERON PHARMACEUTICALS INC. | REGN | RYAN ARTHUR F Director | 100 | $954.22 | $95,422 | 18,382 (Direct) | View |
2024-02-01 Sale | 2024-02-02 4:02 pm | REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial | 273 | $945.61 | $258,152 | 14,947 (Indirect Direct) | View |
2024-01-30 Sale | 2024-01-31 4:52 pm | REGENERON PHARMACEUTICALS INC. | REGN | Bassler Bonnie L Director | 827 | $959 | $793,093 | 2,209 (Direct) | View |
2024-01-23 Sale | 2024-01-25 4:18 pm | REGENERON PHARMACEUTICALS INC. | REGN | GOLDSTEIN JOSEPH L Director | 2,707 | $950 | $2,571,650 | 6,382 (Direct) | View |
2024-01-02 Sale | 2024-01-04 4:20 pm | REGENERON PHARMACEUTICALS INC. | REGN | YANCOPOULOS GEORGE Bd. Co-Chair, President & CSO | 16,848 | $900 | $15,163,200 | 1,217,856 (Indirect Direct) | View |
2024-01-02 Sale | 2024-01-04 4:17 pm | REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial | 274 | $873.91 | $239,451 | 15,220 (Indirect Direct) | View |
2024-01-03 Sale | 2024-01-04 4:11 pm | REGENERON PHARMACEUTICALS INC. | REGN | Bassler Bonnie L Director | 826 | $914 | $754,964 | 4,643 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-03-13 Exercise | 2024-03-15 4:01 pm | N/A 2024-12-16 | REGENERON PHARMACEUTICALS INC. | REGN | MURPHY ANDREW J EVP Research | 20,000 | $0 | 72,616 (Direct) | View |
2024-03-13 Exercise | 2024-03-15 4:01 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | MURPHY ANDREW J EVP Research | 20,000 | $399.66 | 72,616 (Direct) | View |
2024-03-13 Tax Withholding | 2024-03-15 4:01 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | MURPHY ANDREW J EVP Research | 14,217 | $971.82 | 72,616 (Direct) | View |
2024-02-26 Exercise | 2024-02-28 4:04 pm | N/A 2025-01-02 | REGENERON PHARMACEUTICALS INC. | REGN | SING GEORGE L Director | 1,000 | $0 | 33,837 (Direct) | View |
2024-02-26 Exercise | 2024-02-28 4:04 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | SING GEORGE L Director | 500 | $413.33 | 33,837 (Direct) | View |
2024-02-26 Gift | 2024-02-28 4:04 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development | 1,020 | $0 | 61,438 (Direct) | View |
2024-02-26 Exercise | 2024-02-26 4:07 pm | N/A 2026-09-09 | REGENERON PHARMACEUTICALS INC. | REGN | Bassler Bonnie L Director | 854 | $0 | 1,382 (Direct) | View |
2024-02-26 Exercise | 2024-02-26 4:07 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | Bassler Bonnie L Director | 854 | $391.92 | 1,382 (Direct) | View |
2024-02-22 Exercise | 2024-02-26 4:07 pm | N/A 2025-01-02 | REGENERON PHARMACEUTICALS INC. | REGN | SING GEORGE L Director | 3,500 | $0 | 41,675 (Direct) | View |
2024-02-22 Exercise | 2024-02-26 4:07 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | SING GEORGE L Director | 1,500 | $413.33 | 41,675 (Direct) | View |
2024-02-15 Exercise | 2024-02-20 4:03 pm | N/A 2024-12-16 | REGENERON PHARMACEUTICALS INC. | REGN | YANCOPOULOS GEORGE Bd. Co-Chair, President & CSO | 172,723 | $0 | 1,266,978 (Direct) | View |
2024-02-15 Exercise | 2024-02-20 4:03 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | YANCOPOULOS GEORGE Bd. Co-Chair, President & CSO | 172,723 | $399.66 | 1,266,978 (Direct) | View |
2024-02-15 Tax Withholding | 2024-02-20 4:03 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | YANCOPOULOS GEORGE Bd. Co-Chair, President & CSO | 123,601 | $953.83 | 1,266,978 (Direct) | View |
2024-02-09 Exercise | 2024-02-13 4:04 pm | N/A 2029-12-11 | REGENERON PHARMACEUTICALS INC. | REGN | Van Plew Daniel P EVP & General Mgr, Industrial | 35,375 | $0 | 56,522 (Direct) | View |
2024-02-09 Exercise | 2024-02-13 4:04 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | Van Plew Daniel P EVP & General Mgr, Industrial | 12,250 | $372.46 | 56,522 (Direct) | View |
2024-02-09 Exercise | 2024-02-13 4:04 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | Van Plew Daniel P EVP & General Mgr, Industrial | 23,125 | $381.4 | 56,522 (Direct) | View |
2024-02-09 Tax Withholding | 2024-02-13 4:04 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | Van Plew Daniel P EVP & General Mgr, Industrial | 24,941 | $951.68 | 56,522 (Direct) | View |
2024-02-08 Exercise | 2024-02-12 4:02 pm | N/A 2025-01-02 | REGENERON PHARMACEUTICALS INC. | REGN | SING GEORGE L Director | 1,000 | $0 | 48,675 (Direct) | View |
2024-02-08 Exercise | 2024-02-12 4:02 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | SING GEORGE L Director | 1,000 | $413.33 | 48,675 (Direct) | View |
Ownership | 2024-02-08 4:01 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | Pitofsky Jason Vice President, Controller | 0 | $0 | 15,816 (Direct) | View |
2024-02-02 Exercise | 2024-02-06 4:08 pm | N/A 2024-12-16 | REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development | 30,750 | $0 | 70,495 (Direct) | View |
2024-02-02 Tax Withholding | 2024-02-06 4:08 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development | 22,713 | $956.65 | 70,495 (Direct) | View |
2024-02-02 Exercise | 2024-02-06 4:08 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development | 30,750 | $399.66 | 70,495 (Direct) | View |
2024-02-02 Exercise | 2024-02-06 4:08 pm | N/A 2027-12-12 | REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO | 400 | $0 | 35,750 (Direct) | View |
2024-02-02 Tax Withholding | 2024-02-06 4:08 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO | 281 | $956.65 | 35,750 (Direct) | View |
2024-02-02 Exercise | 2024-02-06 4:08 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO | 400 | $378.98 | 35,750 (Direct) | View |
2024-01-31 Exercise | 2024-02-02 4:02 pm | N/A 2027-12-12 | REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO | 400 | $0 | 36,031 (Direct) | View |
2024-01-31 Tax Withholding | 2024-02-02 4:02 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO | 282 | $953.42 | 36,031 (Direct) | View |
2024-01-31 Exercise | 2024-02-02 4:02 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO | 400 | $378.98 | 36,031 (Direct) | View |
2024-01-30 Exercise | 2024-01-31 4:52 pm | N/A 2028-01-02 | REGENERON PHARMACEUTICALS INC. | REGN | Bassler Bonnie L Director | 827 | $0 | 2,209 (Direct) | View |
2024-01-30 Exercise | 2024-01-31 4:52 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | Bassler Bonnie L Director | 827 | $380.95 | 2,209 (Direct) | View |
2024-01-23 Exercise | 2024-01-25 4:18 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | GOLDSTEIN JOSEPH L Director | 2,707 | $625.6 | 6,382 (Direct) | View |
2024-01-23 Exercise | 2024-01-25 4:18 pm | N/A 2032-01-03 | REGENERON PHARMACEUTICALS INC. | REGN | GOLDSTEIN JOSEPH L Director | 2,707 | $0 | 6,382 (Direct) | View |
2024-01-23 Exercise | 2024-01-25 4:17 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | Fenimore Christopher R. SVP Controller | 5,000 | $555.67 | 29,350 (Direct) | View |
2024-01-23 Exercise | 2024-01-25 4:17 pm | N/A 2024-12-16 | REGENERON PHARMACEUTICALS INC. | REGN | Fenimore Christopher R. SVP Controller | 10,000 | $0 | 29,350 (Direct) | View |
2024-01-23 Exercise | 2024-01-25 4:17 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | Fenimore Christopher R. SVP Controller | 5,000 | $399.66 | 29,350 (Direct) | View |
2024-01-23 Tax Withholding | 2024-01-25 4:17 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | Fenimore Christopher R. SVP Controller | 7,569 | $948.5 | 29,350 (Direct) | View |
2024-01-23 Exercise | 2024-01-25 4:17 pm | N/A 2027-12-12 | REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO | 1,600 | $0 | 49,400 (Direct) | View |
2024-01-24 Tax Withholding | 2024-01-25 4:17 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO | 352 | $951.26 | 49,400 (Direct) | View |
2024-01-23 Tax Withholding | 2024-01-25 4:17 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO | 776 | $948.5 | 49,400 (Direct) | View |
2024-01-23 Exercise | 2024-01-25 4:17 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO | 1,600 | $378.98 | 49,400 (Direct) | View |
2024-01-17 Exercise | 2024-01-18 4:02 pm | N/A 2027-12-12 | REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO | 500 | $0 | 37,441 (Direct) | View |
2024-01-17 Tax Withholding | 2024-01-18 4:02 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO | 354 | $932.34 | 37,441 (Direct) | View |
2024-01-17 Exercise | 2024-01-18 4:02 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO | 500 | $378.98 | 37,441 (Direct) | View |
2024-01-12 Exercise | 2024-01-17 4:03 pm | N/A 2027-12-12 | REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO | 800 | $0 | 37,795 (Direct) | View |
2024-01-12 Tax Withholding | 2024-01-17 4:03 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO | 568 | $928.18 | 37,795 (Direct) | View |
2024-01-12 Exercise | 2024-01-17 4:03 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO | 800 | $378.98 | 37,795 (Direct) | View |
2024-01-04 Tax Withholding | 2024-01-08 4:02 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO | 342 | $917.05 | 38,363 (Direct) | View |
2024-01-04 Exercise | 2024-01-08 4:02 pm | N/A 2027-12-12 | REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO | 500 | $0 | 38,363 (Direct) | View |
2024-01-04 Exercise | 2024-01-08 4:02 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO | 500 | $378.98 | 38,363 (Direct) | View |
2024-01-03 Exercise | 2024-01-04 4:22 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | Fenimore Christopher R. SVP Controller | 5,000 | $555.67 | 36,919 (Direct) | View |
2024-01-03 Exercise | 2024-01-04 4:22 pm | N/A 2024-12-16 | REGENERON PHARMACEUTICALS INC. | REGN | Fenimore Christopher R. SVP Controller | 10,000 | $0 | 36,919 (Direct) | View |
2024-01-03 Exercise | 2024-01-04 4:22 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | Fenimore Christopher R. SVP Controller | 5,000 | $399.66 | 36,919 (Direct) | View |
2024-01-03 Tax Withholding | 2024-01-04 4:22 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | Fenimore Christopher R. SVP Controller | 7,512 | $912.3 | 36,919 (Direct) | View |
2024-01-03 Exercise | 2024-01-04 4:19 pm | N/A 2024-12-16 | REGENERON PHARMACEUTICALS INC. | REGN | LAROSA JOSEPH J EVP General Counsel and Secret | 34,000 | $0 | 43,265 (Direct) | View |
2024-01-03 Exercise | 2024-01-04 4:19 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | LAROSA JOSEPH J EVP General Counsel and Secret | 34,000 | $399.66 | 43,265 (Direct) | View |
2024-01-03 Tax Withholding | 2024-01-04 4:19 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | LAROSA JOSEPH J EVP General Counsel and Secret | 24,493 | $912.3 | 43,265 (Direct) | View |
2024-01-02 Exercise | 2024-01-04 4:19 pm | N/A 2027-12-12 | REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO | 1,750 | $0 | 55,792 (Direct) | View |
2024-01-02 Tax Withholding | 2024-01-04 4:19 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO | 421 | $888.34 | 55,792 (Direct) | View |
2024-01-03 Tax Withholding | 2024-01-04 4:19 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO | 688 | $912.3 | 55,792 (Direct) | View |
2024-01-02 Exercise | 2024-01-04 4:19 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO | 1,750 | $378.98 | 55,792 (Direct) | View |
2024-01-02 Option Award | 2024-01-04 4:17 pm | N/A 2034-01-02 | REGENERON PHARMACEUTICALS INC. | REGN | Schenkein David P Director | 550 | $0 | 790 (Direct) | View |
2024-01-02 Option Award | 2024-01-04 4:16 pm | N/A 2034-01-02 | REGENERON PHARMACEUTICALS INC. | REGN | Guarini Kathryn Director | 550 | $0 | 790 (Direct) | View |
2024-01-02 Option Award | 2024-01-04 4:15 pm | N/A 2034-01-02 | REGENERON PHARMACEUTICALS INC. | REGN | Thompson Craig B. Director | 1,742 | $0 | 2,061 (Direct) | View |
2024-01-02 Option Award | 2024-01-04 4:11 pm | N/A 2034-01-02 | REGENERON PHARMACEUTICALS INC. | REGN | COLES N ANTHONY Director | 1,742 | $0 | 3,000 (Direct) | View |
2024-01-03 Exercise | 2024-01-04 4:11 pm | N/A 2028-01-02 | REGENERON PHARMACEUTICALS INC. | REGN | Bassler Bonnie L Director | 826 | $0 | 4,643 (Direct) | View |
2024-01-02 Option Award | 2024-01-04 4:11 pm | N/A 2034-01-02 | REGENERON PHARMACEUTICALS INC. | REGN | Bassler Bonnie L Director | 1,742 | $0 | 4,643 (Direct) | View |
2024-01-03 Exercise | 2024-01-04 4:11 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | Bassler Bonnie L Director | 826 | $380.95 | 4,643 (Direct) | View |